Edan Instruments Inc - Asset Resilience Ratio

Latest as of September 2025: 12.01%

Edan Instruments Inc (300206) has an Asset Resilience Ratio of 12.01% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Edan Instruments Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥300.95 Million
≈ $44.04 Million USD Cash + Short-term Investments

Total Assets

CN¥2.51 Billion
≈ $366.77 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2021)

This chart shows how Edan Instruments Inc's Asset Resilience Ratio has changed over time. See net assets of Edan Instruments Inc for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Edan Instruments Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Edan Instruments Inc (300206) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥300.95 Million 12.01%
Total Liquid Assets CN¥300.95 Million 12.01%

Asset Resilience Insights

  • Moderate Liquidity: Edan Instruments Inc has 12.01% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Edan Instruments Inc Industry Peers by Asset Resilience Ratio

Compare Edan Instruments Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Xiangyu Medical Co. Ltd. A
SHG:688626
Medical Devices 1.53%
Xvivo Perfusion AB
ST:XVIVO
Medical Devices 12.30%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
Medical Devices 14.72%
EBR Systems Inc
AU:EBR
Medical Devices 54.70%
PetVivo Holdings Inc
NASDAQ:PETV
Medical Devices 2.18%

Annual Asset Resilience Ratio for Edan Instruments Inc (2014–2021)

The table below shows the annual Asset Resilience Ratio data for Edan Instruments Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 4.92% CN¥100.82 Million
≈ $14.75 Million
CN¥2.05 Billion
≈ $299.70 Million
-8.42pp
2020-12-31 13.34% CN¥301.41 Million
≈ $44.11 Million
CN¥2.26 Billion
≈ $330.57 Million
+3.26pp
2019-12-31 10.08% CN¥150.96 Million
≈ $22.09 Million
CN¥1.50 Billion
≈ $219.06 Million
+9.05pp
2018-12-31 1.04% CN¥14.94 Million
≈ $2.19 Million
CN¥1.44 Billion
≈ $210.95 Million
-7.70pp
2017-12-31 8.73% CN¥124.61 Million
≈ $18.23 Million
CN¥1.43 Billion
≈ $208.83 Million
+2.17pp
2016-12-31 6.56% CN¥96.25 Million
≈ $14.08 Million
CN¥1.47 Billion
≈ $214.73 Million
-13.83pp
2015-12-31 20.39% CN¥296.19 Million
≈ $43.34 Million
CN¥1.45 Billion
≈ $212.55 Million
+14.67pp
2014-12-31 5.73% CN¥77.59 Million
≈ $11.35 Million
CN¥1.36 Billion
≈ $198.29 Million
--
pp = percentage points

About Edan Instruments Inc

SHE:300206 China Medical Devices
Market Cap
$1.19 Billion
CN¥8.11 Billion CNY
Market Cap Rank
#8390 Global
#2105 in China
Share Price
CN¥13.99
Change (1 day)
+1.75%
52-Week Range
CN¥11.10 - CN¥15.60
All Time High
CN¥25.00
About

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and te… Read more